Substance(s)

• (2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidine-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridine-2-yl)-4-fluoropyrrolidine-2-carboxamide
• 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker
• Coversin
• Eculizumab
• Fc- and CDR-modified humanised monoclonal antibody against C5
• Myristoylated-peptidyl-recombinant Human CD59
• PEGylated peptide inhibitor of complement C3
• S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)

Tradename(s)

• SOLIRIS
• ULTOMIRIS